This study involved acute myeloid leukemia, not PC, but the principles involved may translate to some extent: medicalxpress.com/news/2021...
Not sure this article has any practical application for any of us (yet) but I thought it was interesting to consider that as much as we might want to "put our cancer to sleep" temporarily, to delay progression and relieve symptoms, there are also times when we want our cancer cells to NOT be in a state of hiding/hibernation... namely, when we are trying to kill them with chemo.
Could this mean chemo or ADT might be less effective when done concurrently, rather than sequentially, since either one of those therapies might be inducing a protective state of senescence that limits the overall kill rate by the other therapy? Or am I way off on that?
An excerpt:
"For years, cancer researchers have studied how tumors are able to rebound after they appear to be completely wiped out by chemotherapy. One theory has been that because not all cells within a tumor are the same at the genetic level—a condition called tumor heterogeneity—a small subset of cells are able to resist treatment and begin growing again. Another theory involves the idea of tumor stem cells—that some of the cells within a tumor have special properties that allow them to re-form a tumor after chemotherapy has been given.
The idea that senescence is involved does not replace these other theories. In fact, it could provide new insight into explaining these other processes. Researchers found that when AML cells were exposed to chemotherapy, a subset of the cells went into a state of hibernation, or senescence, while at the same time assuming a condition that looked very much like inflammation. They looked similar to cells that have undergone an injury and need to promote wound healing—shutting down the majority of their functions while recruiting immune cells to nurse them back to health.
These characteristics are also commonly seen in developing embryos that temporarily shut down their growth due to lack of nutrition, a state called embryonic diapause. It's not a special process, but normal biological activity that's playing out in the context of tumors.
These findings have implications for developing new drug combinations that could block senescence. Further research revealed that this inflammatory senescent state was induced by a protein called ATR, suggesting that blocking ATR could be a way to prevent cancer cells from adopting this condition. Two other groups reported that the role of senescence is important not just for AML, but for recurrent cases of breast cancer, prostate cancer and gastrointestinal cancers as well."